Women at Risk for Breast Cancer Should Participate in Decisions About Risk-reducing Drugs

According to a draft recommendation recently introduced by the U.S. Preventive Services Task Force (USPSTF), physicians should strive to engage women at increased risk of breast cancer in the process of making decisions about medications that can reduce their risk. At-risk women who are deemed to be at low risk for adverse effects from these drugs could benefit from taking medications such as tamoxifen or raloxifene.
Source: AAFP Health of the Public - Category: Primary Care Source Type: news